UNSPSC 51101697: Bidimazium iodide

This classification denotes an antihelminthic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2D4432ZP6M. European Medicines Agency schedules Bidimazium iodide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05823MIG.

Bidimazium iodide generally arises in the molecular formula C26H25N2S.I. The term BIDIMAZIUM IODIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, no. 10 1972, list 12.) Most nations schedule bidimazium iodide under HS 29341000 and SITC 51579. As of Q4 2014, BIDIMAZIUM IODIDE remains the US FDA Preferred Term for this commodity. Bidimazium iodide bears US NLM identifiers UMLS ID C2825733 and NCI Concept Code C81724. SMILES: I.s1c([n](c(c2ccc(cc2)c2ccccc2)c1)C)/C=C\c1ccc(N(C)C)cc1.

UNSPSC 51101697 Bidimazium iodide is a Commodity code that, based on recent state and local solicitations, encompasses pharmaceutical and medical supply procurement rather than a single chemical compound. State and local governments are buying naloxone and drug deactivation systems, generic pharmaceuticals, over-the-counter products, and medical and first aid supplies through this code's scope. The issuing bodies include county health departments (Seminole County, Florida), state health agencies (Texas Health and Human Services Commission), municipal fire departments (Tampa Fire Department), and regional cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance). The work ranges from direct procurement of emergency response supplies for rescue divisions to strategic pharmacy benefit program development and multi-source generic pharmaceutical contracting across member jurisdictions.

Recent activity centers on Florida, Texas, and Minnesota. Seminole County, Florida issued IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries and a two-year contract term with one-year renewal option. The City of Tampa issued ITB 26P00145 in March 2026 for medical and first aid supplies for the Fire Department Rescue Division—169 line items estimated at $700,000 and designated as a sheltered market opportunity for certified Small Local Business Enterprises with a 5% bid discount. The Texas Health and Human Services Commission posted RFI HHS0017013 in April 2026 to gather market intelligence on direct-to-manufacturer prescription programs, with responses informing future formal procurement strategy. MMCAP, administered by Minnesota's Department of Administration, issued RFP S1070000015802 in January 2026 for generic multi-source pharmaceuticals and OTC products distributed across participating state and local facilities, with proposals due March 26, 2026 and awards effective July 1, 2026 through authorized wholesalers AmerisourceBergen, Cardinal Health, and Morris & Dickson.